Advanced Therapies Europe

Our CEO is speaking at this event.

This event brings together the cell and gene therapy community from across Europe. It will be commercially and strategically focused and offer an intimate setting so attendees will have the opportunity to connect and gain a 360-degree view on the current landscape of the industry.

CEO and bit.bio founder Mark Kotter will present a case study: novel synbio approaches for a reliable and consistent supply of human cells to precisely match the needs of the patient and the disease.

This will be part of a session on new and enabling technologies and includes a Q&A session.